EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Ischemic and bleeding outcomes by diabetes status in patients receiving ticagrelor monotherapy after percutaneous coronary intervention: an updated meta-analysis

Muhammad Ahmed, Faiqa Iqbal, Muhammad Talha Safdar, Barka Sajid, Muhammad Ahmed Ali Fahim, Salim Surani

Global Cardiology · 31.03.2026 · 4 (1)

DOI: 10.4081/cardio.2026.99 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Global Cardiology, online erschienen am 31.03.2026. Verfasst von Muhammad Ahmed und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ticagrelor monotherapy after percutaneous coronary intervention (PCI) has been proposed to reduce bleeding risk while maintaining ischemic protection. The objective of this paper is to describe differences in ischemic and bleeding outcomes between patients with and without diabetes mellitus who were treated with ticagrelor monotherapy following PCI. A systematic review and meta-analysis were conducted using MEDLINE, Scopus, and Cochrane databases through 15th July 2025. Eligible studies included post hoc analyses of randomized trials comparing ticagrelor monotherapy outcomes between diabetic and non-diabetic patients. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. Four trials were included with a total population of 18,596. Diabetic patients had significantly higher risk of major adverse cardiovascular events (RR 1.84, 95% CI 1.44-2.36; p

Zitieren

APA

Ahmed, M., Iqbal, F., Safdar, M. T., Sajid, B., Fahim, M. A. A., & Surani, S. (2026). Ischemic and bleeding outcomes by diabetes status in patients receiving ticagrelor monotherapy after percutaneous coronary intervention: an updated meta-analysis. Global Cardiology, 4(1). https://doi.org/10.4081/cardio.2026.99

Vancouver

Ahmed M, Iqbal F, Safdar MT, Sajid B, Fahim MAA, Surani S. Ischemic and bleeding outcomes by diabetes status in patients receiving ticagrelor monotherapy after percutaneous coronary intervention: an updated meta-analysis. Global Cardiology. 2026;4(1). doi:10.4081/cardio.2026.99

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Muhammad and Iqbal, Faiqa and Safdar, Muhammad Talha and Sajid, Barka and Fahim, Muhammad Ahmed Ali and Surani, Salim},
  title = {Ischemic and bleeding outcomes by diabetes status in patients receiving ticagrelor monotherapy after percutaneous coronary intervention: an updated meta-analysis},
  journal = {Global Cardiology},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.4081/cardio.2026.99}
}
Kostenlos starten →